DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Samuel JA, Wilson JW, Bandos H et al.
NSABP B-36: a randomized phase III trial comparing six cycles of 5-fluorouracil (5-FU), epirubicin, and cyclophosphamide (FEC) to four cycles of adriamycin and cyclophosphamide (AC) in patients (pts) with node-negative breast cancer.
San Antonio Breast Cancer Symposium; 2014 S3-02
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.